Overview of Dr. Raza
Dr. Azra Raza is an oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from Dow University of Health Sciences and has been in practice 42 years. She specializes in hematologic oncology and is experienced in hypertension, coronary artery disease, preventive cardiology, hematologic oncology, and lipid metabolism disorders.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 1981 - 1982
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1979 - 1980
MedStar Franklin Square Medical CenterResidency, Internal Medicine, 1978 - 1979
University of MarylandResidency, Family Medicine, 1977 - 1978- University at BuffaloResidency, Pediatrics, 1977 - 1977
Dow University of Health SciencesClass of 1975
Certifications & Licensure
NY State Medical License 1981 - 2026
MA State Medical License 2004 - 2009
IL State Medical License 1993 - 2005
OH State Medical License 1989 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML Start of enrollment: 2009 Jan 01
- Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome Start of enrollment: 2009 Dec 01
- Revlimid in Transfusion Dependent Patients Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 19 citationsA phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloprolif...Nelli Bejanyan, Ramon V. Tiu, Azra Raza, Ania Jankowska, Matt Kalaycio
Cancer. 2012-08-15 - 315 citationsLong-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio
Journal of Hematology & Oncology. 2017-02-22 - 1456 citationsA Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisSrdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta
The New England Journal of Medicine. 2012-03-01
Press Mentions
Why the Way We Care for Babies Is MESSED UP, They LIED About Eggs, When Medicine Gets It Wrong, How We Can Fix It & More with Dr. Marty MakaryNovember 2nd, 2024- Dr. Stavroula Kousteni: Nobody Should Be Dying from CancerOctober 1st, 2022
- Cancer Shouldn’t Pose a Threat to Our Lives. We Should Find It FirstApril 13th, 2022
- Join now to see all
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
MagnaCare PPOMultiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
